Cantor Fitzgerald’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Cantor Fitzgerald's MRNA Position: Q2 2026 in Review
Cantor Fitzgerald increased its Moderna (MRNA) stake by 128% in Q2 2026, buying an estimated $660K and bringing the position to 22,772 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #208.
Cantor Fitzgerald first reported a position in MRNA in Q2 2022 and has held it in 12 quarters since. The position peaked at $4.34M in Q2 2022. 786 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Cantor Fitzgerald held 22,772 shares of Moderna worth $1.59M as of Q2 2026.
- Cantor Fitzgerald bought 12,763 Moderna shares in Q2 2026, an estimated $660K.
- Moderna made up 0.02% of Cantor Fitzgerald's portfolio in Q2 2026, its #208 holding.
- Cantor Fitzgerald first reported a position in Moderna in Q2 2022 and has held it in 12 quarters since.
- Cantor Fitzgerald's Moderna position peaked at $4.34M in Q2 2022.
- 786 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.